GlycoMimetics Inc (GLYC)
0.32
-0.01
(-3.03%)
USD |
NASDAQ |
Nov 21, 16:00
0.3104
-0.01
(-3.00%)
After-Hours: 05:43
GlycoMimetics Price to Book Value: 1.814 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.814 |
| November 20, 2024 | 1.870 |
| November 19, 2024 | 2.149 |
| November 18, 2024 | 2.354 |
| November 15, 2024 | 2.358 |
| November 14, 2024 | 2.264 |
| November 13, 2024 | 2.279 |
| November 12, 2024 | 2.242 |
| November 11, 2024 | 2.367 |
| November 08, 2024 | 2.338 |
| November 07, 2024 | 2.381 |
| November 06, 2024 | 2.134 |
| November 05, 2024 | 2.211 |
| November 04, 2024 | 2.324 |
| November 01, 2024 | 2.169 |
| October 31, 2024 | 2.306 |
| October 30, 2024 | 2.588 |
| October 29, 2024 | 2.778 |
| October 28, 2024 | 0.9534 |
| October 25, 2024 | 0.9806 |
| October 24, 2024 | 0.9851 |
| October 23, 2024 | 1.006 |
| October 22, 2024 | 0.9353 |
| October 21, 2024 | 0.9069 |
| October 18, 2024 | 0.8979 |
| Date | Value |
|---|---|
| October 17, 2024 | 0.8984 |
| October 16, 2024 | 0.8894 |
| October 15, 2024 | 0.8638 |
| October 14, 2024 | 0.8423 |
| October 11, 2024 | 0.8508 |
| October 10, 2024 | 0.8179 |
| October 09, 2024 | 0.8134 |
| October 08, 2024 | 0.8661 |
| October 07, 2024 | 0.8843 |
| October 04, 2024 | 0.9058 |
| October 03, 2024 | 0.9081 |
| October 02, 2024 | 0.8729 |
| October 01, 2024 | 0.9398 |
| September 30, 2024 | 0.9579 |
| September 27, 2024 | 0.5368 |
| September 26, 2024 | 0.548 |
| September 25, 2024 | 0.5127 |
| September 24, 2024 | 0.5287 |
| September 23, 2024 | 0.5287 |
| September 20, 2024 | 0.5297 |
| September 19, 2024 | 0.5464 |
| September 18, 2024 | 0.5271 |
| September 17, 2024 | 0.5303 |
| September 16, 2024 | 0.5213 |
| September 13, 2024 | 0.5464 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4159
Minimum
Jun 16 2022
6.777
Maximum
Apr 01 2024
1.518
Average
1.118
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.234 |
| Arbutus Biopharma Corp | 6.134 |
| Revance Therapeutics Inc | -- |
| FibroGen Inc | -- |
| Cidara Therapeutics Inc | 1.063 |
Price to Book Value Related Metrics
| Price | 0.32 |
| Earnings Yield | -193.8% |
| Market Cap | 20.63M |